Abstract
Prostate specific antigen (PSA) is the most important marker for prostate cancer. Antibodies against minor variants of PSA may be useful in the development of novel diagnostic tests for prostate cancer, but it has been difficult to produce such antibodies by protein immunization. In this study, we have compared the characteristics of monoclonal antibodies (MAbs) obtained by genetic immunization with those obtained by protein immunization. The whole coding region of PSA-cDNA was cloned in a mammalian expression vector pCDNA-3. Six mice were immunized four times by intra-muscular (i.m.) injection of the PSA-pCDNA3 plasmid. The MAbs produced were characterized with respect to subclass, epitope specificity, binding to various molecular forms of PSA and affinity. After intra-muscular injection of DNA, anti-PSA antibodies were detected in the serum of all mice, but the antibody titers were markedly lower than after protein immunization. After fusion of the spleen cells from the mice, five hybridomas producing MAbs to PSA were obtained. The MAbs were of IgG1 and IgG2a isotype and they all recognized equally different forms of free PSA, namely enzymatically active, nicked and proPSA. Epitope mapping showed that these MAbs reacted with ...Continue Reading
References
Mar 12, 1992·Nature·D C TangS A Johnston
Dec 27, 1990·European Journal of Biochemistry·A ChristenssonH Lilja
Apr 25, 1991·The New England Journal of Medicine·W J CatalonaG L Andriole
Oct 8, 1987·The New England Journal of Medicine·T A StameyE Redwine
Nov 1, 1994·Protein Science : a Publication of the Protein Society·B O VilloutreixJ H Griffin
Mar 19, 1993·Science·J B UlmerA Friedman
Dec 24, 1996·Proceedings of the National Academy of Sciences of the United States of America·G J NabelA E Chang
Aug 19, 1997·Proceedings of the National Academy of Sciences of the United States of America·N L LetvinJ W Shiver
Nov 5, 1997·Seminars in Immunology·H L Robinson, C A Torres
Mar 21, 1998·Nature Medicine·M L HedleyR Urban
Jun 24, 1998·Proceedings of the National Academy of Sciences of the United States of America·M SedegahS L Hoffman
Aug 12, 1998·The Journal of Investigative Dermatology·T TütingL D Falo
Jan 1, 1999·Oncogene·J J KimH Shoemaker
Jan 16, 1999·Hybridoma·K E KilpatrickJ T Hutchins
Jul 16, 1999·Virology·D LoiratM L Michel
Jan 11, 2000·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·U H StenmanJ Hilgers
Oct 18, 2000·Journal of Immunological Methods·C A VelikovskyM Spitz
Feb 21, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·Gary OttDerek T O'Hagan
Oct 2, 2002·The Journal of Infectious Diseases·Clement A MesedaJerry P Weir
Feb 1, 2003·Clinical Chemistry·Harry J LintonStephen D Mikolajczyk
Aug 12, 2003·Nature Biotechnology·Ross S Chambers, Stephen Albert Johnston
Sep 27, 2003·Methods : a Companion to Methods in Enzymology·Hanns Hauser, Si-Yi Chen
Dec 25, 2003·Thrombosis Research·Takayuki YamadaTetsuhito Kojima
Citations
Nov 10, 2009·Analytical and Bioanalytical Chemistry·Brian C MacknessMelisenda J McDonald
Apr 25, 2007·Hybridoma·Lorena MaestreGiovanna Roncador
May 18, 2006·Hybridoma·Nam-Kyu LimKyung-Soo Inn
Dec 30, 2011·PloS One·Michael C BrownKlaus Lindpaintner
Jun 17, 2008·Vaccine·Carolina Bellini PariseSang Won Han
Jul 28, 2016·Monoclonal Antibodies in Immunodiagnosis and Immunotherapy·David J HawksworthSharmila Manoj
Jun 22, 2005·World Journal of Gastroenterology : WJG·Li-Mei ZhangLi-Qin Wang
Apr 7, 2016·Emerging Microbes & Infections·Shuying LiuShan Lu
Apr 18, 2008·Biotechnology Letters·Pieranna Chiarella, Vito Michele Fazio
Oct 1, 2020·International Journal of Molecular Sciences·Julie PelletierJean Sévigny